Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04965688 · ClinicalTrials.gov registry record · Phase 2
Biology Guided Therapy for Breast Cancer for ER Positive
A Phase 2 study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT04965688: Clinical Trial Phase 2 study, sponsored by Inova Health Care Services.
NCT04965688 is a Phase 2 study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04965688, a Phase 2 study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
There are several approved and guideline-recommended treatments for metastatic, estrogen receptor-positive breast cancer that has progressed on an aromatase inhibitor and a CDK4/6 inhibitor. Right now, doctors do not have a good way of choosing between these treatments. Scientists we work with have come up with ways to use the biology of the tumor to try to predict which treatment is best. This study is being done to test if those predictions are right and to learn more about these tumors to design better treatments in the future.
Primary Outcome
No data displayed because Outcome Measure has zero total participants analyzed.
Interventions
- DRUG Biopsy-Guided Therapy Selection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-08-08 |
| Est. Completion | 2024-03-13 |
| Phase | Phase 2 |
Why NCT04965688 stopped before completion
NCT04965688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Biopsy-Guided Therapy Selection is the first listed.
NCT04965688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04965688 about?
NCT04965688 is a clinical study titled "Biology Guided Therapy for Breast Cancer for ER Positive". There are several approved and guideline-recommended treatments for metastatic, estrogen receptor-positive breast cancer that has progressed on an aromatase inhibitor and a CDK4/6 inhibitor. Right now, doctors do not have a good way of choosing between these treatments. Scientists we work with have ...
What is the current status of trial NCT04965688?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2021-08-08. Estimated completion is 2024-03-13.
What interventions are being tested in trial NCT04965688?
The interventions under investigation include: Biopsy-Guided Therapy Selection (DRUG).
Who is sponsoring clinical trial NCT04965688?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04965688's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI